Subject
Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine
Reference77 articles.
1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017
2. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur. Heart J.,2019
3. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia;Ferrari;Eur. Hear. J.,2016
4. Atherogenic markers in predicting cardiovascular risk and targeting residual cardiovascular risk;Catapano;Atheroscler. X.,2019
5. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes;Kones;Vasc. Health Risk Manag.,2013
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献